BioPrinting: Organovo Strikes Agreements

By on July 23rd, 2011 in Usage

Tags: ,

Organovo, the bioprinting startup that hopes to eventually print whole replacement human organs, has struck agreements with two pharma companies to assist in drug testing. Organovo will print tiny scaffolds on which human tissue can grow into lifelike shapes. These shapes tend to be better grounds for drug testing, as cells in a simple petri dish tend to behave differently than they do in a human body. Testing efficiency should improve. 
Meanwhile, the income generated from these agreements will enable Organovo to maintain operations while they continue to work on their eventual goal of replicating human organs. Evidently Organovo is not yet “in the black”, but such is the way of startup companies. 

By Kerry Stevenson

Kerry Stevenson, aka "General Fabb" has written over 8,000 stories on 3D printing at Fabbaloo since he launched the venture in 2007, with an intention to promote and grow the incredible technology of 3D printing across the world. So far, it seems to be working!

Leave a comment